PharmaCielo Ltd. PCLOF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

24/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

PharmaCielo Ltd. (PCLOF) reported total assets of $8.56M and total liabilities of $23.9M for fiscal year 2025, resulting in total equity of $-15.34M.

The company held $289.01K in cash and short-term investments. Total debt stood at $18.63M, with net debt of $18.34M. The Debt-to-Equity (D/E) ratio was -1.21 (conservative).

Current ratio is 0.15, which may signal tight short-term liquidity. Interest coverage is -1.5x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (29/100) — Total assets $8.56M and equity $-15.34M support the company's competitive scale

Overall SharesGrow Score: 23/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

24/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

29/100

→ Income

✓

GROWTH

83/100

→ Income

✗

INCOME

10/100

→ Income

PharmaCielo Ltd. Balance Sheet History

Metric	FY2025	FY2024	FY2023	FY2022
Total Assets	$8.56M	$18.39M	$22.29M	$25.12M
Total Liabilities	$23.9M	$25.91M	$23.97M	$18.72M
Total Debt	$18.63M	$20.52M	$18.31M	$12.59M
Cash & Investments	$289.01K	$147.94K	$62.18K	$325.98K
Total Stockholders Equity	$-15.34M	$-7.52M	$-1.68M	$6.39M